Trends in Anti-VEGF Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy. Ophthalmology. Retina Azad, A. D., Chen, E. M., Hinkle, J., Rayess, N., Wu, D., Eliott, D., Mruthyunjaya, P., Parikh, R. 2020

Abstract

Enrollees with PDR with or without DME were identified from 2012 to 2019. We observed a decline in the utilization of PRP and an increase in anti-VEGF utilization.

View details for DOI 10.1016/j.oret.2020.10.002

View details for PubMedID 33039592